Free Trial

Brokers Set Expectations for Henry Schein FY2024 Earnings

Henry Schein logo with Medical background

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Stock analysts at Barrington Research raised their FY2024 EPS estimates for shares of Henry Schein in a report released on Wednesday, November 6th. Barrington Research analyst M. Petusky now anticipates that the company will earn $4.75 per share for the year, up from their prior forecast of $4.72. Barrington Research has a "Outperform" rating and a $82.00 price target on the stock. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the prior year, the business earned $1.32 EPS. The firm's revenue was up .4% compared to the same quarter last year.

HSIC has been the topic of a number of other reports. UBS Group lowered their price target on shares of Henry Schein from $75.00 to $72.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 7th. Baird R W upgraded Henry Schein from a "hold" rating to a "strong-buy" rating in a report on Monday, July 22nd. Robert W. Baird cut their price target on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 7th. JPMorgan Chase & Co. dropped their target price on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a research report on Monday, August 12th. Finally, Evercore ISI boosted their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research report on Tuesday, October 8th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, five have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $77.50.

Read Our Latest Stock Analysis on HSIC

Henry Schein Stock Performance

Shares of Henry Schein stock traded down $1.43 during trading hours on Friday, hitting $68.00. 871,840 shares of the company were exchanged, compared to its average volume of 1,357,247. The stock has a market capitalization of $8.62 billion, a price-to-earnings ratio of 25.71, a P/E/G ratio of 2.08 and a beta of 0.87. The business has a 50-day moving average of $70.56 and a 200-day moving average of $69.78. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. Henry Schein has a 1 year low of $62.12 and a 1 year high of $82.63.

Insider Buying and Selling

In related news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company's stock, valued at approximately $4,978,026.90. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.14% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Henry Schein

Institutional investors have recently bought and sold shares of the stock. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Henry Schein by 11.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 27,894 shares of the company's stock worth $2,186,000 after purchasing an additional 2,954 shares during the last quarter. Nordea Investment Management AB grew its stake in Henry Schein by 8.9% in the 1st quarter. Nordea Investment Management AB now owns 9,785 shares of the company's stock valued at $744,000 after buying an additional 798 shares during the last quarter. Daiwa Securities Group Inc. raised its holdings in Henry Schein by 11.0% in the 1st quarter. Daiwa Securities Group Inc. now owns 12,869 shares of the company's stock worth $972,000 after acquiring an additional 1,279 shares during the period. Empirical Finance LLC lifted its position in Henry Schein by 3.5% during the 1st quarter. Empirical Finance LLC now owns 4,764 shares of the company's stock worth $360,000 after acquiring an additional 160 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. boosted its holdings in Henry Schein by 64.2% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company's stock valued at $3,138,000 after acquiring an additional 16,241 shares during the period. 96.62% of the stock is currently owned by institutional investors.

About Henry Schein

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Should you invest $1,000 in Henry Schein right now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Revolutionizing Logistics: Dot Ai Corporation CEO Ed Nabrotzky Talks IPO and Innovations
Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar
Top 3 Stocks Under $20 with Strong Buy Ratings and Growth Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines